JOURNAL OF CLINICAL LABORATORY ANALYSIS
Scope & Guideline
Innovating methodologies for the future of laboratory science.
Introduction
Aims and Scopes
- Clinical Diagnostics and Biomarkers:
The journal emphasizes research on novel biomarkers and diagnostic techniques, particularly those that enhance the accuracy and efficiency of disease detection and monitoring. - Molecular Diagnostics and Genomics:
There is a significant focus on molecular methods, including next-generation sequencing and PCR techniques, for the diagnosis of various genetic and infectious diseases. - Laboratory Methodologies and Quality Control:
The journal includes studies evaluating and optimizing laboratory methodologies, emphasizing the importance of quality control in clinical laboratories. - Therapeutic Monitoring and Drug Response:
Research related to the monitoring of therapeutic drug levels and responses in various patient populations is a key area, particularly in chronic diseases and cancer. - Infectious Disease Diagnostics:
Given the ongoing global health challenges, the journal frequently publishes articles related to the rapid diagnosis and management of infectious diseases, including COVID-19. - Clinical Applications of Artificial Intelligence:
Emerging trends in the application of artificial intelligence and machine learning in laboratory diagnostics are increasingly highlighted, showcasing innovative approaches to enhance clinical decision-making.
Trending and Emerging
- Integration of Artificial Intelligence in Diagnostics:
There is a marked increase in research focusing on the application of artificial intelligence and machine learning to improve diagnostic accuracy and efficiency in laboratory settings. - Liquid Biopsy and Circulating Biomarkers:
The trend towards utilizing liquid biopsies and circulating biomarkers for cancer diagnosis and monitoring is gaining momentum, highlighting the shift towards less invasive diagnostic methods. - Point-of-Care Testing Innovations:
Emerging technologies for point-of-care testing are increasingly featured, emphasizing the need for rapid and accessible diagnostic solutions in various clinical settings. - Microbiome Research:
Studies exploring the role of the microbiome in health and disease are on the rise, indicating a growing interest in understanding the complex interactions between microbiota and clinical outcomes. - Personalized Medicine and Pharmacogenomics:
There is an increasing focus on the role of pharmacogenomics in personalized medicine, with research aimed at tailoring treatments based on individual genetic profiles. - COVID-19 Related Research:
The impact of the COVID-19 pandemic is reflected in a surge of studies related to diagnostics, treatment monitoring, and understanding the long-term effects of the virus, showcasing the journal's responsiveness to global health challenges.
Declining or Waning
- Traditional Biochemical Assays:
There has been a noticeable decline in studies solely focused on traditional biochemical assays, as newer technologies and methodologies gain traction in laboratory diagnostics. - Basic Hematology Studies:
Research centered on fundamental hematological parameters seems to be less frequent, possibly due to the development of more sophisticated diagnostic tools and techniques. - Single-Center Studies:
The prevalence of studies conducted in single-center settings appears to be decreasing, with a growing emphasis on multicenter collaborations and large-scale studies to enhance generalizability. - Histopathology-Based Diagnoses:
The journal has seen a decline in articles focused purely on histopathological methods, as molecular and genetic approaches become more dominant in diagnostic pathology. - Non-Clinical Laboratory Studies:
There is a waning interest in studies that do not directly relate to clinical applications or laboratory practices, as the journal increasingly prioritizes research with direct clinical implications.
Similar Journals
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Fostering Knowledge in Molecular Biology and HealthEXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.
LABORATORY INVESTIGATION
Elevating Standards in Laboratory InvestigationLaboratory Investigation is a premier academic journal published by Elsevier Science Inc, specializing in the fields of Pathology, Forensic Medicine, Cell Biology, and Molecular Biology. With its ISSN 0023-6837 and E-ISSN 1530-0307, this journal has been a significant contributor to scientific discourse since its inception in 1952, converging into its current form by 2024. It holds an impressive standing in its respective fields, featuring a 2023 Journal Rank of Q2 in both Cell Biology and Molecular Biology, and an elite Q1 ranking in Pathology and Forensic Medicine, reflecting its influence and quality of research, as seen in its Scopus ranks—17th out of 208 in Pathology and Forensic Medicine. Although it does not offer Open Access options, the journal remains a vital resource for researchers, professionals, and students who seek to disseminate and engage with high-caliber research findings. The importance of Laboratory Investigation is underscored by its commitment to advancing the understanding of laboratory and translational medicine, paving the way for innovations that enhance clinical practices.
JOURNAL OF BIOMEDICAL SCIENCE
Empowering research through open access in biomedicine.JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.
Journal of Mass Spectrometry and Advances in the Clinical Lab
Bridging Theory and Practice in Mass SpectrometryJournal of Mass Spectrometry and Advances in the Clinical Lab, published by Elsevier, serves as a premier resource within the fields of clinical biochemistry, medical laboratory technology, microbiology, and spectroscopy. Launched in 2021 with an Open Access model, this journal enhances the accessibility of innovative research, making it an ideal platform for researchers, practitioners, and students alike. With an impressive impact factor reflected in its quartile rankings—Q2 in Clinical Biochemistry and Microbiology, and Q1 in Medical Laboratory Technology and Spectroscopy—this journal ensures high visibility and credibility. The journal's diverse indexing and significant standings in Scopus rankings highlight its commitment to advancing knowledge and fostering collaboration among professionals in laboratory sciences. Endorsed by a robust editorial board comprising leading experts, the journal aims to disseminate cutting-edge findings and methodologies, contributing to significant advancements in clinical and scientific laboratory practices. By bridging theoretical frameworks and practical applications, this journal plays a crucial role in the continuous evolution of laboratory technologies, thereby empowering readers to push the boundaries of research and innovation in their fields.
Internal Medicine
Unveiling the Nuances of Internal MedicineInternal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.
ANNALS OF CLINICAL AND LABORATORY SCIENCE
Innovating Diagnostic Practices Through Peer ReviewANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.
Breast Cancer-Basic and Clinical Research
Advancing knowledge, transforming treatment.Breast Cancer-Basic and Clinical Research is a premier open access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of breast cancer through a comprehensive approach that integrates basic and clinical research findings. Since its inception in 2008, this journal has aimed to serve as a vital platform for researchers, healthcare professionals, and students in the fields of oncology and cancer research, providing them with timely access to significant new research, clinical trials, and innovative methodologies. With its current rankings placing it in the Q3 quartile for Cancer Research and Oncology, it reflects a steady commitment to quality and relevance, ranking #167/404 in Medicine - Oncology and #133/230 in Biochemistry, Genetics and Molecular Biology - Cancer Research as of 2023. The journal is designed to foster dialogue and collaboration across disciplines, enabling advancements in therapeutic strategies and patient care. Researchers and professionals will find it an invaluable resource as it continues to push the frontiers of knowledge in breast cancer research.
ANNALES DE BIOLOGIE CLINIQUE
Fostering Collaboration in Clinical and Laboratory ScienceANNALES DE BIOLOGIE CLINIQUE is a prominent French journal dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Immunology, and Microbiology. Published by JOHN LIBBEY EUROTEXT LTD, this journal has been a pivotal resource since its inception in 1945, offering a rich archive of original research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and clinical applications. Despite its ranking in the Q4 quartile within several scientific categories according to the 2023 Scopus rankings—positioning it at #395/636 in General Medicine and #198/221 in General Biochemistry—ANNALES DE BIOLOGIE CLINIQUE serves as a vital platform for emerging researchers and seasoned professionals alike, fostering collaboration and innovation in these vital areas of health science. As an essential tool for researchers and scholars, the journal does not currently provide open access; however, it continuously strives to enhance its impact and visibility in the scientific community through rigorous peer-reviewed content and educational contributions.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Advancing the Frontiers of Clinical PathologyThe American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.
Malaysian Journal of Pathology
Empowering the future of pathology with rigorous scholarship.Malaysian Journal of Pathology, published by the MALAYSIAN JOURNAL PATHOLOGY, stands as a pivotal resource in the fields of pathology and medicine, contributing rich insights since its inception in 1979. This peer-reviewed journal, based in Malaysia, is dedicated to disseminating original research, review articles, and case studies that advance the understanding of disease mechanisms and diagnostics. With a current impact factor reflecting its ranked positioning—Q4 in Cell Biology, Q4 in Histology, and Q3 in both Miscellaneous Medicine and Pathology & Forensic Medicine—this journal serves as an essential platform for researchers, clinicians, and students alike. Although it operates without open access, its scholarly rigor and contributions are well recognized, holding ranks such as #84 in Pathology and Forensic Medicine according to Scopus. The Malaysian Journal of Pathology is committed to fostering innovation and excellence in medical research, making it an invaluable tool for professionals seeking to stay abreast of significant advancements in the pathology domain.